Smith+Nephew (LSE: SN, NYSE:SNN), the global medical technology company, announces it will provide a glimpse into the future at AAOS 2024. With a first opportunity to see a forthcoming new feature* for its CORI◊ Surgical System, this exclusive image-agnostic* robotic-assisted surgical solution is designed to further help personalize surgery, advance efficiencies, and optimize performance across Smith+Nephew’s orthopaedic reconstruction portfolio.
The power of one robotic-assisted platform
Smith+Nephew’s CORI Surgical System – a next-generation handheld robotic platform - supports the entire continuum of care in knee arthroplasty (unicompartmental, total, revision) and a comprehensive solution for navigated total hip arthroplasty (THA). Robotic-assisted surgery has been shown to help improve surgical outcomes and cost effectiveness compared to conventional techniques.1-3
Personalizing surgery
Delivering solutions for differing patient types coupled with planning and execution tools is essential to personalizing surgery. By individualizing the episode of care, patients have shown better outcomes such as early recovery and early functional outcomes compared to conventional UKA surgery.12-15
RI.KNEE ROBOTICS v2.0 – Personalized Planning software powered by AI - provides AI-powered reference values as guidance for planning and enables surgeons to set preferences for initial implant starting positions that are customized to patient deformity.
“Smith+Nephew’s technology platform is the only one in the market that allows for personalized planning using simulation and AI. The RI.HIP Modeler allows for impingement analysis based on an individual patient profile, while RI.KNEE software utilizes AI for personalized planning and implant placement. When introducing personalized options to manage specific pathologies, we see increased patient satisfaction and clinical outcomes. These continue to elevate the level of care we as surgeons may provide to our patients,” said Thorsten Seyler, MD PhD, Associate Professor of Orthopedics at Duke University.
Smith+Nephew's CORI Surgical System and RI.KNEE Robotics v2.0
Proven economic benefits
Smith+Nephew’s robotic-assisted procedural solutions have positive effects on the healthcare economic landscape. For example, patients who received Smith+Nephew robotic-assisted UKA could be discharged in less than 24 hours without complications or readmissions.14
To learn more about how these advancements in robotic-assisted and personalized surgery support ‘Precision in Motion’ - the company’s uncompromising commitment to freedom of movement - please visit the Smith+Nephew booth (#5469) at the American Academy of Orthopaedic Surgeons 2024 Annual Meeting from February 12-16 in San Francisco, CA.
- ends –
Enquiries
Media
David Snyder +1 978-749-1440
Smith+Nephew
References
* Pending 510(k) clearance
About Smith+Nephew
Smith+Nephew is a portfolio medical technology company focused on the repair, regeneration and replacement of soft and hard tissue. We exist to restore people’s bodies and their self-belief by using technology to take the limits off living. We call this purpose ‘Life Unlimited’. Our 19,000 employees deliver this mission every day, making a difference to patients’ lives through the excellence of our product portfolio, and the invention and application of new technologies across our three global business units of Orthopaedics, Sports Medicine & ENT and Advanced Wound Management.
Founded in Hull, UK, in 1856, we now operate in more than 100 countries, and generated annual sales of $5.2 billion in 2022. Smith+Nephew is a constituent of the FTSE100 (LSE:SN, NYSE:SNN). The terms ‘Group’ and ‘Smith+Nephew’ are used to refer to Smith & Nephew plc and its consolidated subsidiaries, unless the context requires otherwise.
For more information about Smith+Nephew, please visit www.smith-nephew.com and follow us on X, LinkedIn, Instagram or Facebook.
Forward-looking Statements
This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading margins, market trends and our product pipeline are forward-looking statements. Phrases such as "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions are generally intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith+Nephew, these factors include: risks related to the impact of Covid, such as the depth and longevity of its impact, government actions and other restrictive measures taken in response, material delays and cancellations of elective procedures, reduced procedure capacity at medical facilities, restricted access for sales representatives to medical facilities, or our ability to execute business continuity plans as a result of Covid; economic and financial conditions in the markets we serve, especially those affecting healthcare providers, payers and customers (including, without limitation, as a result of Covid); price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls or other problems with quality management systems or failure to comply with related regulations; litigation relating to patent or other claims; legal and financial compliance risks and related investigative, remedial or enforcement actions; disruption to our supply chain or operations or those of our suppliers (including, without limitation, as a result of Covid); competition for qualified personnel; strategic actions, including acquisitions and dispositions, our success in performing due diligence, valuing and integrating acquired businesses; disruption that may result from transactions or other changes we make in our business plans or organisation to adapt to market developments; relationships with healthcare professionals; reliance on information technology and cybersecurity; disruptions due to natural disasters, weather and climate change related events; changes in customer and other stakeholder sustainability expectations; changes in taxation regulations; effects of foreign exchange volatility; and numerous other matters that affect us or our markets, including those of a political, economic, business, competitive or reputational nature. Please refer to the documents that Smith+Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith+Nephew's most recent annual report on Form 20-F, which is available on the SEC’s website at www. sec.gov, for a discussion of certain of these factors.
责任编辑:GlobeNewswire
图片版权归原作者所有,如有侵权请联系我们,我们立刻删除。
随机文章